MI
INSM icon

Motiv8 Investments’s Insmed INSM Stock Holding History

Motiv8 Investments’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$9 Buy
+51
New +$9.31K ﹤0.01% 477

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Motiv8 Investments's INSM Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Insmed (INSM) in Q4 2025: 51 shares worth $9. The stake represents ﹤0.01% of the portfolio and ranks #477 among its holdings.

677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Motiv8 Investments held 51 shares of Insmed worth $9 as of Q4 2025.
  • Insmed was a new Motiv8 Investments position in Q4 2025.
  • Insmed made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #477 holding.
  • 677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.